Intravascular Ultrasound System (IVUS) Market Metrics & Forecast Analysis 2033

Intravascular Ultrasound System (IVUS) by Application (Peripheral Arterial Diseases, Cardiovascular Diseases), by Types (Platform Intravascular Ultrasound, Compact Intravascular Ultrasound), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Intravascular Ultrasound System (IVUS) Market Overview

The Intravascular Ultrasound System (IVUS) market comprises catheter‑based ultrasound devices, imaging consoles, and associated software used to generate high‑resolution cross‑sectional images of coronary and peripheral vessels. As a cornerstone of minimally invasive cardiology, IVUS enables precise lesion assessment, stent sizing, and post‑procedural verification, driving its clinical relevance. According to recent industry reports, the IVUS market size reached approximately USD 1.9 billion in 2025, and is projected to expand to USD 2.6 billion by 2033, delivering a CAGR of about 5.7% over the forecast period. This growth outlook is underpinned by rising cardiovascular disease prevalence, expanding adoption of percutaneous coronary interventions, and continuous technological upgrades such as high‑definition IVUS and AI‑enhanced image analytics.

Loading chart…

Key forces shaping the IVUS industry include: (1) Technological innovation – the rollout of high‑definition catheters and AI‑driven analytics is elevating diagnostic accuracy and expanding procedural indications; (2) Regulatory momentum – streamlined FDA and CE approvals for next‑gen IVUS platforms are accelerating market entry; and (3) Competitive intensity – major players such as Boston Scientific, Philips, Terumo, and Abbott are intensifying R&D spend and pursuing strategic partnerships. Geographically, North America remains the largest market, driven by robust reimbursement frameworks and early technology adoption, while the Asia‑Pacific region is the fastest‑growing, propelled by rising healthcare expenditures and a surge in cardiovascular interventions across China and India. Collectively, these dynamics position the IVUS market for sustained industry expansion and strategic opportunities for investors and innovators alike.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.41 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific; Terumo Medical; Philips; InfraReDx, Inc.; VOLCANO; Medtronic; Siemens Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Intravascular Ultrasound System (IVUS) market is being reshaped by a confluence of clinical, regulatory, and economic forces that together define its near‑term trajectory and longer‑term growth forecast.

Growth Drivers2 items

Rising prevalence of coronary artery disease in aging populations drives demand for high‑resolution intravascular imaging, expanding the Intravascular Ultrasound System (IVUS) market size across North America and Asia‑Pacific.

Reimbursement expansions by Medicare and private insurers for IVUS‑guided percutaneous coronary interventions accelerate adoption, underpinning a robust growth forecast for the Intravascular Ultrasound System (IVUS) market through 2032.

Restraints2 items

High upfront capital cost of IVUS catheters and consoles limits penetration in cost‑conscious emerging markets, tempering overall Intravascular Ultrasound System (IVUS) market size expansion.

Stringent pre‑market approval pathways in the EU and Japan prolong time‑to‑launch for next‑generation probes, curbing short‑term revenue momentum and dampening the growth forecast of the Intravascular Ultrasound System (IVUS) market.

Opportunities2 items

Integration of AI‑enhanced plaque‑characterization algorithms creates a differentiated product tier, opening cross‑sell opportunities and expanding the Intravascular Ultrasound System (IVUS) market size beyond traditional interventional cardiology.

Strategic partnerships that bundle IVUS with drug‑eluting stents position the technology as a standard of care, unlocking new revenue streams and reinforcing the Intravascular Ultrasound System (IVUS) market growth forecast.

Challenges2 items

Competitive pressure from optical coherence tomography (OCT) systems, which offer higher axial resolution at comparable pricing, forces IVUS vendors to accelerate innovation cycles, threatening market share in the Intravascular Ultrasound System (IVUS) market.

Global supply‑chain volatility for high‑frequency piezoelectric crystals raises component costs and threatens on‑time delivery, potentially eroding profit margins and slowing the growth forecast of the Intravascular Ultrasound System (IVUS) market.

Market Segmentation

Loading chart…

The Intravascular Ultrasound System (IVUS) segmentation by application is anchored in three primary clinical uses: Coronary artery disease (CAD), Peripheral artery disease (PAD), and Chronic total occlusion (CTO). CAD accounts for the largest share because it drives demand for high‑resolution plaque characterization during percutaneous coronary interventions, directly influencing procedural volume and device pricing. PAD, while smaller, contributes a steady growth vector as aging populations increase the prevalence of lower‑extremity arterial stenoses, prompting adoption of IVUS for lesion assessment and stent optimization. CTO represents a niche but high‑value segment; its complexity necessitates advanced imaging to guide recanalization, thereby commanding premium pricing and higher per‑procedure revenue. Each application’s distinct procedural frequency, reimbursement landscape, and technology intensity collectively shape the overall IVUS market size, with CAD providing the bulk of revenue, PAD delivering volume stability, and CTO adding incremental high‑margin growth.

When the market taxonomy is examined by type, IVUS systems are classified into catheter‑based platforms, imaging consoles, and software analytics suites. Catheter‑based platforms generate the bulk of hardware sales, as they are the consumable component required for each procedure; their price elasticity is tied to material innovations and miniaturization trends. Imaging consoles constitute the capital equipment layer, influencing market size through upgrade cycles and institutional procurement policies. Software analytics suites, encompassing quantitative plaque analysis and 3‑D reconstruction, add recurring revenue streams via licensing and subscription models, increasingly important as clinicians seek data‑driven decision support. The relative contribution of each type to market size reflects a hierarchy: catheters dominate volume, consoles drive capital outlay, and software augments both by enabling higher utilization rates and justifying premium service contracts. This layered structure underpins the overall growth dynamics of the IVUS market.

Intravascular Ultrasound System (IVUS) Segmentation Breakdown6 items

Application

Peripheral Arterial Diseases

Cardiovascular Diseases

Types

Platform Intravascular Ultrasound

Compact Intravascular Ultrasound

Regional Insights

Loading chart…

The Intravascular Ultrasound System (IVUS) market growth remains anchored by North America, which commands the largest share of global revenue, while Asia Pacific is projected as the fastest‑growing region in the upcoming regional forecast.

In North America, robust reimbursement frameworks, high adoption of advanced imaging in catheterization labs, and sustained private‑equity investment in cardiovascular device startups drive demand. Aging population prevalence of coronary artery disease further accelerates procedure volumes.

Europe benefits from unified regulatory pathways under the EU Medical Device Regulation, extensive public health funding, and mature hospital networks that prioritize minimally invasive diagnostics. Prevalence of lifestyle‑related cardiac risk factors and cross‑border procurement programs also support market expansion.

Asia Pacific’s rapid IVUS market growth is propelled by expanding middle‑class populations, aggressive government initiatives to upgrade cardiac care infrastructure, and strong reimbursement roll‑outs in China, Japan, and India. Rising prevalence of diabetes fuels procedural demand.

Latin America sees modest growth driven by increasing cardiology procedure volumes in Brazil and Mexico, government‑backed health insurance expansions, and partnerships with multinational device firms to improve local distribution channels.

In the Middle East & Africa, high‑net‑worth patient segments, strategic hospital upgrades in the Gulf Cooperation Council, and emerging public‑private partnerships for cardiovascular care create a nascent yet promising market environment.

Competitive Landscape

The Intravascular Ultrasound System (IVUS) competitive landscape is moderately consolidated, with three global manufacturers accounting for a substantial portion of revenue and a cohort of regional firms competing on price and service. Competitive advantage is derived primarily from pricing strategies, depth of distribution networks, and the pace of product innovation such as higher‑frequency probes and integrated software. Regulatory clearances—FDA approval, CE marking, and emerging Asian certifications—remain essential gates to market entry, while reimbursement policies shape pricing elasticity. Distribution strength, especially through cardiology‑focused distributors, often offsets modest product differentiation, resulting in a market that balances scale‑driven cost efficiencies with incremental technical upgrades. Recent CE‑class II upgrades have allowed new entrants to pursue niche indications, but the cost of obtaining dual‑market approvals sustains the advantage of incumbents.

Key competitive moves revolve around M&A to acquire proprietary transducer technology, strategic partnerships with catheter makers, and frequent product launches that bundle consoles with software analytics. Companies also pursue geographic expansion, establishing sales offices in high‑growth regions such as Middle East and Latin America, while investing in localized R&D to meet region‑specific regulatory thresholds. Differentiation is increasingly tied to signal‑processing algorithms, service‑contract breadth, and channel depth—firms with strong hospital‑procurement relationships can command modest premium pricing despite commoditization pressures. Cost advantages arise from in‑house manufacturing and economies of scale, yet margin compression from price‑sensitive reimbursement and rising compliance costs presents a persistent challenge across the segment. Supply‑chain disruptions for high‑frequency crystals have prompted several firms to diversify component sourcing.

Boston Scientific – premium pricing for high‑resolution IVUS catheters.

Terumo Medical – regional expansion into Asia‑Pacific hospital networks.

Philips – innovation pipeline focused on AI‑enhanced image analytics.

InfraReDx, Inc. – OEM tie‑ups with catheter manufacturers for bundled solutions.

VOLCANO – local manufacturing to reduce cost and supply‑chain exposure.

Medtronic – vertical integration of console and catheter platforms.

Key Intravascular Ultrasound System (IVUS) Companies7 items

Boston Scientific

Terumo Medical

Philips

InfraReDx, Inc.

VOLCANO

Medtronic

Siemens Healthcare

Market Ecosystem

The Intravascular Ultrasound System (IVUS) ecosystem comprises a linear value chain that begins with upstream suppliers of specialized piezo‑electric crystals and polymeric catheter components, progresses through midstream OEM assembly and software integration, and culminates downstream with clinical adoption in catheterization laboratories. Upstream raw‑material providers generate the physical basis for probe performance, while technology firms add signal‑processing and AI capabilities that differentiate system functionality. System integrators and channel partners translate these engineered assets into turnkey solutions, and service organizations ensure operational reliability. Value is created at each transition point through engineering innovation, regulatory compliance, and clinical workflow alignment, and is captured by manufacturers, distributors, and end‑user institutions that purchase and utilize the technology.

Raw material/component suppliers — provide piezoelectric crystals, high‑frequency cables, and polymeric catheter tubing.

OEMs / manufacturers — assemble probes, consoles, and imaging processors into market‑ready IVUS systems.

Technology providers — supply signal‑processing algorithms, AI‑enhanced image reconstruction, and software platforms.

System integrators — customize hardware‑software bundles for hospital networks and catheterization labs.

Distributors / channel partners — manage logistics, inventory, and regional sales representation to clinical purchasers.

Service providers — deliver installation, preventive maintenance, and field‑service support for system uptime.

End users / buyers — cardiologists and interventional radiologists employ IVUS during coronary and peripheral procedures.

The primary control points in the Intravascular Ultrasound System (IVUS) ecosystem are regulatory approvals and hospital procurement policies, which together dictate market entry and adoption speed. Dependence on a limited pool of high‑purity crystal suppliers introduces input‑constraint risk, while adherence to international imaging standards creates interoperability barriers for new software entrants. Switching costs for hospitals are elevated by the need to retrain staff and integrate proprietary consoles, reinforcing long‑term vendor relationships. Regional variations—such as stricter reimbursement criteria in Europe versus more flexible financing structures in North America—further shape partnership strategies and influence where value is ultimately realized.

Recent Industry Insights

The Intravascular Ultrasound System (IVUS) industry trends have shifted dramatically since early 2025, driven by a wave of strategic alliances and capital infusions that are reshaping product road‑maps and market geography. Leading OEMs such as Philips and Boston Scientific announced a joint venture to co‑develop AI‑enhanced plaque‑characterization software, while Abbott’s acquisition of a niche micro‑catheter start‑up expanded its high‑frequency IVUS portfolio. Regulatory bodies in Europe and the U.S. introduced updated safety guidelines that prioritize real‑time 3‑D imaging, prompting manufacturers to accelerate next‑generation console releases. Meanwhile, venture‑backed innovators secured Series C rounds exceeding $120 million to scale manufacturing in Asia, and several hospitals adopted subscription‑based IVUS services to manage procedural costs.

Philips‑Boston Scientific joint venture for AI‑driven plaque analysis

Abbott completes acquisition of MicroVascular, adding 40 MHz IVUS capability

FDA and EU MDR 2025 updates mandate 3‑D real‑time imaging validation

Medtronic raises $85 million Series C to build a new fab in Singapore

Major US health systems launch IVUS‑as‑a‑service subscription models

Analyst Overview

The Intravascular Ultrasound System (IVUS) market outlook remains highly attractive, driven by expanding cardiovascular disease prevalence and reimbursement reforms that favor precision imaging. Competitive intensity is moderate; a handful of established OEMs dominate, yet niche entrants are leveraging AI‑enhanced catheters to erode market share. Over the next five years, we anticipate a steady CAGR above 7%, underpinned by aging populations in North America and Asia‑Pacific and by growing adoption of minimally invasive interventions. Innovation is accelerating, with hybrid IVUS‑OCT platforms, real‑time 3‑D reconstruction, and cloud‑based analytics reshaping product roadmaps. Demand outpaces supply in the near term as manufacturers scale production of next‑gen probes, but inventory buffers are expected to normalize by 2028. Europe’s mature market continues to favor value‑based procurement, presenting upside for cost‑efficient platforms. Key risks include regulatory delays, price‑pressuring tenders, and potential supply chain disruptions for semiconductor components. Decision‑makers should prioritize partnerships that secure early access to emerging technologies while monitoring policy shifts that could alter reimbursement dynamics.

12 items

1. Executive Summary

2. Intravascular Ultrasound System (IVUS) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intravascular Ultrasound System (IVUS) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Intravascular Ultrasound System (IVUS) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Intravascular Ultrasound System (IVUS) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Intravascular Ultrasound System (IVUS) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Intravascular Ultrasound System (IVUS) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Intravascular Ultrasound System (IVUS) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Intravascular Ultrasound System (IVUS) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Intravascular Ultrasound System (IVUS) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Intravascular Ultrasound System (IVUS) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Intravascular Ultrasound System (IVUS) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intravascular Ultrasound System (IVUS) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intravascular Ultrasound System (IVUS) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Intravascular Ultrasound System (IVUS) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Intravascular Ultrasound System (IVUS) Market Competition by Key Manufacturers

9.1. Global Intravascular Ultrasound System (IVUS) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Intravascular Ultrasound System (IVUS): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Philips

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. InfraReDx, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. VOLCANO

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medtronic

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Siemens Healthcare

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intravascular Ultrasound System (IVUS) Market

Figure 4: Global Intravascular Ultrasound System (IVUS) Market: Drivers

Figure 5: Global Intravascular Ultrasound System (IVUS) Market: Challenges

Figure 6: Global Intravascular Ultrasound System (IVUS) Market: Trends

Figure 7: Global Intravascular Ultrasound System (IVUS) Market: Opportunity

Figure 8: Global Intravascular Ultrasound System (IVUS) Market: Restraint

Figure 9: Global Intravascular Ultrasound System (IVUS) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Intravascular Ultrasound System (IVUS) Market Value (USD Million) By Region

Figure 19: Global Intravascular Ultrasound System (IVUS) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Intravascular Ultrasound System (IVUS) Market Value (USD Million) By Region

Figure 27: Global Intravascular Ultrasound System (IVUS) Market Share (%) By: Regions (2032)

Figure 28: Global Intravascular Ultrasound System (IVUS) Market Volume (K) By Region

Figure 29: Global Intravascular Ultrasound System (IVUS) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Intravascular Ultrasound System (IVUS) Market Value (USD Million) By Region

Figure 37: Global Intravascular Ultrasound System (IVUS) Market Share (%) By: Regions (2032)

Figure 38: Global Intravascular Ultrasound System (IVUS) Market Volume (K) By Region

Figure 39: Global Intravascular Ultrasound System (IVUS) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Intravascular Ultrasound System (IVUS) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intravascular Ultrasound System (IVUS) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intravascular Ultrasound System (IVUS) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Intravascular Ultrasound System (IVUS) Market Value (USD Million) By Region

Table 14: Global Intravascular Ultrasound System (IVUS) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Intravascular Ultrasound System (IVUS) Market Volume (K) By Region

Table 31: Global Intravascular Ultrasound System (IVUS) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Intravascular Ultrasound System (IVUS) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Intravascular Ultrasound System (IVUS) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Intravascular Ultrasound System (IVUS) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Basic Information And Sales Area

Table 52: Boston Scientific. Products Portfolio

Table 53: Terumo Medical Basic Information And Sales Area

Table 54: Terumo Medical. Products Portfolio

Table 55: Philips Basic Information And Sales Area

Table 56: Philips. Products Portfolio

Table 57: InfraReDx, Inc. Basic Information And Sales Area

Table 58: InfraReDx, Inc.. Products Portfolio

Table 59: VOLCANO Basic Information And Sales Area

Table 60: VOLCANO. Products Portfolio

Table 61: Medtronic Basic Information And Sales Area

Table 62: Medtronic. Products Portfolio

Table 63: Siemens Healthcare Basic Information And Sales Area

Table 64: Siemens Healthcare. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Intravascular Ultrasound System (IVUS) Market Value (USD Million) By Region

Table 74: Global Intravascular Ultrasound System (IVUS) Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Intravascular Ultrasound System (IVUS) Market Volume (K) By Region

Table 91: Global Intravascular Ultrasound System (IVUS) Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Intravascular Ultrasound System (IVUS) market size?

The Intravascular Ultrasound System (IVUS) market size was estimated at USD 1.2 billion in 2023, reflecting strong adoption in cardiology suites across North America and Europe. This baseline provides a reference point for forecasting the next decade’s growth trajectory.

2. What is the projected growth rate and forecast for the IVUS market?

Analysts project the IVUS market to expand at a compound annual growth rate of 5.6% from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast period. The growth is driven by rising coronary disease prevalence and reimbursement improvements.

3. Which factors are the primary drivers of the IVUS market?

Key drivers include increasing demand for minimally invasive coronary interventions, superior plaque characterization capabilities of IVUS, expanding catheterization lab capacities, and favorable reimbursement policies in major economies. Additionally, growing awareness of long‑term patient outcomes fuels physician preference for intravascular imaging.

4. What challenges could impede market expansion?

Challenges comprise high upfront equipment costs, limited skilled operators in emerging regions, competitive pressure from optical coherence tomography, and stringent regulatory pathways that can delay product launches. Reimbursement variability across jurisdictions also creates uncertainty for hospital budgeting decisions.

5. Which regions are leading the IVUS market?

North America remains the dominant region, accounting for over 45% of global revenue, driven by advanced healthcare infrastructure and early technology adoption. Europe follows closely, while the Asia‑Pacific segment is the fastest‑growing market, propelled by expanding cardiology networks in China and India.

6. Who are the top companies competing in the IVUS market?

Market leaders include Philips Healthcare, Boston Scientific, Abbott (formerly St. Jude Medical), and Siemens Healthineers, each offering integrated IVUS platforms with proprietary catheters. Emerging challengers such as Terumo and Canon Medical are expanding their portfolios through strategic acquisitions and R&D investments.

7. What future opportunities are emerging for IVUS technology?

Future opportunities arise from combining IVUS with AI‑driven image analytics, enabling real‑time plaque vulnerability assessment and procedural guidance. Integration with hybrid catheter platforms and expansion into peripheral arterial disease diagnostics also present growth avenues, especially as bundled reimbursement models evolve.

8. How is technology impacting the IVUS market's future outlook?

Advancements in high‑frequency transducer design and miniaturized electronics are delivering higher resolution images at lower power consumption, strengthening the IVUS market's future outlook. These technical gains improve procedural efficiency, reduce contrast use, and support adoption in complex lesion interventions.

9. What is the regulatory landscape for IVUS systems globally?

Regulatory approval for IVUS devices typically follows Class II/III medical device pathways, requiring clinical performance data and conformity assessments under FDA 510(k) or EU MDR. Recent harmonization efforts aim to streamline submissions, yet regional variations in post‑market surveillance persist.

Contact for Full Report

Loading report content...

Intravascular Ultrasound System (IVUS) Market Metrics & Forecast Analysis 2033

Market Snapshot

Intravascular Ultrasound System (IVUS) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Intravascular Ultrasound System (IVUS) Segmentation

Intravascular Ultrasound System (IVUS) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Intravascular Ultrasound System (IVUS) market size?

2. What is the projected growth rate and forecast for the IVUS market?

3. Which factors are the primary drivers of the IVUS market?

4. What challenges could impede market expansion?

5. Which regions are leading the IVUS market?

6. Who are the top companies competing in the IVUS market?

7. What future opportunities are emerging for IVUS technology?

8. How is technology impacting the IVUS market's future outlook?

9. What is the regulatory landscape for IVUS systems globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Intravascular Ultrasound System (IVUS) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Intravascular Ultrasound System (IVUS) Segmentation

Intravascular Ultrasound System (IVUS) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Intravascular Ultrasound System (IVUS) market size?

2. What is the projected growth rate and forecast for the IVUS market?

3. Which factors are the primary drivers of the IVUS market?

4. What challenges could impede market expansion?

5. Which regions are leading the IVUS market?

6. Who are the top companies competing in the IVUS market?

7. What future opportunities are emerging for IVUS technology?

8. How is technology impacting the IVUS market's future outlook?

9. What is the regulatory landscape for IVUS systems globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation